ArticleCureus2025
Emergency Department Visits for Circulatory System Diseases: A Study of Primary Diagnoses Using National Hospital Ambulatory Medical Care Survey (NHAMCS) Data From 2016 to 2022.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCirculatory system diseases are leading causes of emergency department (ED) visits in the United States. Understanding trends in these visits is crucial for healthcare planning.
objectiveThis study aimed to identify the most frequent primary circulatory system diagnoses presenting to EDs, examine temporal trends in ED visit rates from 2016 to 2022, and assess disparities by patient age, sex, race/ethnicity, insurance status, and geographic region. MATERIALS AND
methodsA cross-sectional analysis of the National Hospital Ambulatory Medical Care Survey (NHAMCS) data (2016-2022) identified ED visits with a primary circulatory disease diagnosis using International Classification of Diseases (ICD) codes. Weighted estimates ensured national representativeness. Descriptive statistics and inferential statistics were used to assess trends. Analyses were performed in STATA 17 (StataCorp., College Station, TX, USA) (p<0.05).
resultsOverall ED visit rates for circulatory diseases rose from 15 per 1,000 in 2016 to 17 per 1,000 in 2019 (p<0.01), declined to 16 per 1,000 in 2020 (p<0.05 vs. 2019), and stabilized at 17 per 1,000 in 2021-2022 (no significant change, p=0.12). Essential hypertension (14%), hypertensive heart or kidney disease (13%), acute myocardial infarction (11%), atrial fibrillation/flutter (10%), and ischemic stroke (8%) represented the five most common primary diagnoses, accounting for over 56% of circulatory presentations. Older adults (65+) exhibited the highest visit rates (peaking at 55 per 1,000 in 2022), males had slightly higher rates than females (18 vs. 16 per 1,000 in 2022), and non-Hispanic Black individuals had persistently elevated rates (28 per 1,000 in 2022) compared to non-Hispanic White individuals (17 per 1,000) and Hispanic individuals (12 per 1,000) (all p<0.05). The Midwest and Northeast regions reported the highest rates, whereas the West had the lowest, underscoring geographic variation in circulatory disease burden. Medicare beneficiaries had the highest utilization (44 per 1,000 in 2022), highlighting insurance-related disparities.
conclusionsIn this nationally representative analysis, primary ED presentations for circulatory diseases were dominated by hypertension-related conditions and acute ischemic events. Stabilization of rates post-2020, particularly among older and Medicare-insured patients, indicates potential targets for intervention. Strengthening primary care access and preventive programs, especially for older adults and non-Hispanic Black individuals, may reduce ED reliance and improve equity in cardiovascular care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.